CELZ

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.2M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$0

Quarter to Jun 30

Net income

$-1.51M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$540.3K total
Hudson Bay Capital Management LP
$196.0KNew
Anson Funds Management LP
$153.0KNew
ARMISTICE CAPITAL, LLC
$60.9KNew
XTX Topco Ltd
$38.5K+86.2%
GEODE CAPITAL MANAGEMENT, LLC
$37.4K-32.6%
VANGUARD CAPITAL MANAGEMENT LLC
$29.5K0.0%
VANGUARD FIDUCIARY TRUST CO
$8.0K0.0%
Tower Research Capital LLC (TRC)
$7.0K+132.0%
Global Retirement Partners, LLC
$6.0K--
UBS Group AG
$3.0KNew
MORGAN STANLEY
$745-3.7%
BARCLAYS PLC
$78New
SBI Securities Co., Ltd.
$62+4200.0%
See all 13 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CELZ

Earnings Per Share

13fpro.ai/company/CELZ

Loading ratio trend…

CELZ key financials by period

Reported revenue, net income and operating margin by fiscal year, from CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s annual filings on SEC EDGAR.

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$6.0K$-6.0M—
FY 2024$11.0K$-5.5M—
FY 2023$9.0K$-5.3M—
FY 2022$88.6K$-10.1M—
FY 2021$87.8K$19.2M—
FY 2020$164.5K$-36.3M—
Source: CELZ filings on SEC EDGAR →

About CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ): stock profile, AI score and financials

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CELZ is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.2m in revenue and is scored on the micro-cap board instead. Top institutional holders of CELZ by reported 13-F value include Hudson Bay Capital Management, Anson Funds Management, ARMISTICE CAPITAL, based on the most recent SEC filings. CELZ trades on the Nasdaq exchange and files with the SEC under CIK 1187953. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CELZ daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1187953 →